PuSH - Publication Server of Helmholtz Zentrum München

Lohöfer, F.* ; Buchholz, R.* ; Glinzer, A.* ; Huber, K. ; Haas, H.* ; Kaissis, G.* ; Feuchtinger, A. ; Aichler, M. ; Sporns, P.B.* ; Höltke, C.* ; Stölting, M.* ; Schilling, F.* ; Botnar, R.M.* ; Kimm, M.A.* ; Faber, C.* ; Walch, A.K. ; Zernecke, A.* ; Karst, U.* ; Wildgruber, M.*

Mass Spectrometry imaging of atherosclerosis-affine Gadofluorine following Magnetic Resonance imaging.

Sci. Rep. 10:79 (2020)
Publ. Version/Full Text Research data DOI
Open Access Gold
Creative Commons Lizenzvertrag
Molecular imaging of atherosclerosis by Magnetic Resonance Imaging (MRI) has been impaired by a lack of validation of the specific substrate responsible for the molecular imaging signal. We therefore aimed to investigate the additive value of mass spectrometry imaging (MSI) of atherosclerosis-affine Gadofluorine P for molecular MRI of atherosclerotic plaques. Atherosclerotic Ldlr(-/-) mice were investigated by high-field MRI (7T) at different time points following injection of atherosclerosis-affine Gadofluorine P as well as at different stages of atherosclerosis formation (4, 8, 16 and 20 weeks of HFD). At each imaging time point mice were immediately sacrificed after imaging and aortas were excised for mass spectrometry imaging: Matrix Assisted Laser Desorption Ionization (MALDI) Imaging and Laser Ablation - Inductively Coupled Plasma - Mass Spectrometry (LA-ICP-MS) imaging. Mass spectrometry imaging allowed to visualize the localization and measure the concentration of the MR imaging probe Gadofluorine P in plaque tissue ex vivo with high spatial resolution and thus adds novel and more target specific information to molecular MR imaging of atherosclerosis.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Plaque; Tissue; Quantification; Model; Ms
Reviewing status